Lemonade insider files Rule 144 to sell 5,000 shares on NYSE
Rhea-AI Filing Summary
The Form 144 filed for Lemonade, Inc. (LMND) reports a proposed sale of 5,000 common shares through Oppenheimer & Co. on the NYSE with an aggregate market value of $272,950. The shares were acquired on 06/07/2020 under an employee stock option plan and are to be paid in cash upon exercise on 08/13/2025. Outstanding shares are listed as 73,886,417, so the proposed sale equals roughly 0.0068% of outstanding stock. The filing also discloses three prior sales by the same person totaling 15,000 shares for $735,000 on 06/23/2025, 08/05/2025, and 08/11/2025. Signature and notice date fields are not shown in the provided content.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider option exercise and sale; transaction size is immaterial relative to outstanding shares and unlikely to move the market.
The Form 144 documents a proposed sale of 5,000 common shares valued at $272,950 via Oppenheimer on the NYSE. Relative to the 73,886,417 shares outstanding, this represents approximately 0.0068%, which is negligible for market impact. The seller also disclosed three recent sales totaling 15,000 shares for $735,000, indicating prior monetizations of option-derived holdings. The securities were acquired under an employee stock option plan and are to be paid in cash upon exercise, reducing uncertainty about payment method.
TL;DR: The filing shows compliance with Rule 144 disclosure requirements, but the provided content lacks visible signature and notice date fields.
The notice includes standard Rule 144 representations and identifies the acquisition source as the issuer via an employee stock option plan. The broker and exchange are disclosed as Oppenheimer & Co. and NYSE. However, the provided extract does not display a completed signature block or a notice date, limiting confirmation of filing completion from the content alone. Multiple recent sales by the same person are disclosed and are transparent in amount and timing.